Avant Diagnostics: Avant Diagnostics is majorly shaking up cancer research by commercializing next generation technologies that will help physicians and patients customize their treatments in the fields of oncology and neurology.
Hf-asset.com: Hengfai Asset Management produces consistent returns through market volatility while protecting principal and maintaining regular liquidity to investors.
Infusion 51a: Infusion 51a is a newly formed fund that invests in the most underappreciated companies of the life sciences and renewable energy industries, with an immediate focus on biopharmaceutical firms.
International Infusion: International Infusion is a leading venture capital firm promoting disruptive technologies in the life sciences, renewable energy industries, and beyond.
Northwestern Trauma and Surgical Initiative: NTSI is a powerful team of medical professionals providing sustainable access to surgical care through education and research in under-resourced settings.
Sadanah Foundation: The Sadanah Foundation seeks to provide sustainable access to health care and education in under-resourced regions of the globe.
Singapore E-development: Singapore E-development brings together leaders of biomedical sciences, information technology, and international property development. SED is working to build a major business enterprise that Singapore can be proud of.
A Think Tank working to develop disruptive technologies aimed to change the world.
Vivacitas Oncology: Vivacitas was co-founded in 2015 with the aim of optimizing and perfecting well-known chemotherapy treatments.